Polymorphisms in the promoter region of RANTES in Han Chinese and their relationship with systemic lupus erythematosus

Archives of Dermatological Research

Volumn 297, Issue 3, 2005, Pages 108-113

  Ye, Dong Qing ^a   Yang, Shi Gui ^a   Li, Xiang Pei ^b   Hu, Yi Song ^a   Yin, Jing ^a   Zhang, Guo Qing ^a   Liu, Hui Hui ^a   Wang, Qian ^a   Zhang, Ke Chun ^a   Dong, Ma Xia ^c   Zhang, Xue Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Chemokines; Polymorphism; Systemic lupus erythematosus

Indexed keywords

CHEMOKINE; RANTES;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHINESE; CONTROL GROUP; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; EOSINOPHIL; FEMALE; GENE FREQUENCY; GENE LOCUS; GENOTYPE; HUMAN; INFLAMMATION; KIDNEY INJURY; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RACE DIFFERENCE; RISK; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS; VOLUNTEER;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; KIDNEY DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RANTES;

EID: 26444471946     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-005-0581-9     Document Type: Article

References (40)

1. Kotzin BL, Kozora E (2001) Anti-DNA meets NMDA in neuropsychiatric lupus. Nat Med 7(11):1175-1176
2. Dongqing Ye (2001) Dermatosis epidemiology. The people health publishing house, Beijing, pp 480-487
3. Grennan DM, Parfitt A, Manolios N, Huang Q, Hyland V, Dunckley H, Doran T, Gatenby P, Badcock C (1997) Family and twin studies in systemic lupus erythematosus. Dis Markers 13(2):93-98
4. Shai R, Quismorio FP Jr, Li L et al (1999) Genome-wide screen for systemic lupus erythematosus susceptibility genes in multiplex families. Hum Mol Genet 8(4):639-644
5. Bengtsson AA, Rylander L, Hagmar L, Kwon OJ, Morrison J, Wallace DJ, Neuwelt CM, Brautbar C, Gauderman WJ, Jacob CO (2002) Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden. Rheumatology (Oxford) (5):563-571
6. Olson JM, Song Y, Dudek DM, Moser KL, Kelly JA, Bruner GR, Downing KJ, Berry CK, James JA, Harley JB (2002) A genome screen of systemic lupus erythematosus using affected-relative-pair linkage analysis with covariates demonstrates genetic heterogeneity. Genes Immun 3(s1):S5-S12
7. Lindqvist AK, Steinsson K, Johanneson B, Kristjansdottir H, Arnasson A, Grondai G, Jonasson I, Magnusson V, Sturfelt G, Truedsson L, Svenungsson E, Lundberg I, Terwilliger JD, Gyllensten UB, Alarcon-Riquelme ME (2000) A susceptibility locus for human systemic lupus erythematosus (hSLE1) on chromosome 2q. J Autoimmun 14(2):169-178
8. Magnusson V, Lindqvist AK, Castillejo-Lopez C, Kristjansdottir H, Steinsson K, Grondai G, Sturfelt G, Truedsson L, Svenungsson E, Lundberg I, Gunnarsson I, Bolstad AI, Haga HJ, Jonsson R, Klareskog L, Alcocer-Varela J, Alarcon-Segovia D, Terwilliger JD, Gyllensten UB, Alarcon-Riquelme ME (2000) Fine mapping of the SLEB2 locus involved in susceptibility to systemic lupus erythematosus. Genomics 70(3):307-314
9. Gaffney PM, Kearns GM, Shark KB, Ortmann WA, Selby SA, Malmgren ML, Rohlf KE, Ockenden TC, Messner RP, King RA, Rich SS, Behrens TW (1998) A genome-wide search for susceptibility genes in human systemic lupus erythematosus sib-pair families. Proc Natl Acad Sci USA 95(25):14875-14879
10. Gaffney PM, Ortmann WA, Selby SA, Shark KB, Ockenden TC, Rohlf KE, Walgrave NL, Boyum WP, Malmgren ML, Miller ME, Kearns GM, Messner RP, King RA, Rich SS, Behrens TW (2000) Genome screening in human systemic lupus erythematosus: results from a second Minnesota cohort and combined analysis of 187 sib-pair families. Am J Hum Genet 66(2):547-556
11. Lindqvist AK, Alarcon-Riquelme ME (1999) The genetics of systemic lupus erythematosus. Scand J Immunol 50(6):562-571
12. Maddison P, Farewell V, Isenberg D, Aranow C, Bae SC, Barr S, Buyon J, Fortin P, Ginzler E, Gladman D, Hanly J, Manzi S, Nived O, Petri M, Ramsey-Goldman R, Sturfelt G (2002) Systemic Lupus International Collaborating Clinics. The rate and pattern of organ damage in late onset systemic lupus erythematosus. J Rheumatol 29(5):913-917
13. Hashimoto H, Nishimura Y, Dong RP, Kimura A, Sasazuki T, Yamanaka K, Tokano Y, Murashima A, Kabasawa K, Hirose S (1994) HLA antigens in Japanese patients with systemic lupus erythematosus. Scand J Rheumatol 23(4):191-196
14. Koene HR, Kleijer M, Swaak AJ, Sullivan KE, Bijl M, Petri MA, Kallenberg CG, Roos D, von dem Borne AE, de Haas M (1998) The Fc gammaRbA-158F allele is a risk factor for systemic lupus erythematosus. Arthritis Rheum 41(10):1813-1818
15. Zuniga R, Ng S, Peterson MG, Reveille JD, Baethge BA, Alarcon GS, Salmon JE (2001) Low-binding alleles of Fcgamma receptor types aA and bA are inherited independently and are associated with systemic lupus erythematosus in Hispanic patients. Arthritis Rheum 44(2):361-367
16. Morita C, Horiuchi T, Tsukamoto H, Hatta N, Kikuchi Y, Arinobu Y, Otsuka T, Sawabe T, Harashima S, Nagasawa K, Niho Y (2001) Association of tumor necrosis factor receptor type a polymorphism 196R with systemic lupus erythematosus in the Japanese. Molecular and functional analysis. Arthritis Rheum 44(12):2819-2827
17. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP (2001) Novel single nucleotide polymorphisms in the distal IL-10 promotor affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 166(6):15-22
18. Mehrian R, Quismorio FP Jr, Strassmann G, Stimmler MM, Horwitz DA, Kitridou RC, Gauderman WJ, Morrison J, Brautbar C, Jacob CO (1998) Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum 41(4):596-602
19. Horiuchi T, Nishizaka H, Yasunaga S, Higuchi M, Tsukamoto H, Hayashi K, Nagasawa K (1999) Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese. Rheumatology 38(6):516-520
20. Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392(6676):565-568
21. Hsieh SC, Yu HS, Lin WW, Sun KH, Tsai CY, Huang DF, Tsai YY, Yu CL (2003) Anti-SSB/La is one of the antineutrophil autoantibodies responsible for neutropenia and functional impairment of polymorphonuclear neutrophils in patients with systemic lupus erythematosus. Clin Exp Immunol 131(3):506-516
22. Kim HL, Lee DS, Yang SH (2002) The polymorphism of monocyte chemoattractant protein-1 is associated with the renal disease of SLE. Am J Kidney Dis 40(6):1146-1152
23. Chen S, Liu Z, Chen H, Zhou H, Wang J, Li L (2002) Glomerular chemokine expression and the effect of steroid and cyclophosphamide pulse therapy in human crescentic glomerulonephritis. Chin Med J (Engl) 115(9):1301-1307
24. Mancardi S, Vecile E, Dusetti N, Calvo E, Stanta G, Burrone OR, Dobrina A (2003) Evidence of CXC, CC and C chemokine production by lymphatic endothelial cells. Immunology 108(4):523-523
25. Aoki M, Pawankar R, Niimi Y, Kawana S (2003) Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int Arch Allergy Immunol 130(3):216-223
26. Dorner BG, Steinbach S, Huser MB, Kroczek RA, Scheffold A (2003) Single-cell analysis of the murine chemokines MIP-1alpha, MIP-1beta, RANTES and ATAC/lymphotactin by flow cytometry. J Immunol Methods 274(1-2):83-91
27. Nelson PJ, Kim HT, Manning WC, Goralski TJ, Krensky AM (1993) Genomic organization and transcriptional regulation of the RANTES chemokine gene. J Immunol 151(5):2601-2612
28. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu JK, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y, Ohishi T, Fukutake K, Maruyama Y, Yashiki S, Sonoda S, Nakamura T, Nagai Y, Iwamoto A, Shioda T (1999) Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 96(8):4581-4585
29. Alam R (1997) Chemokines in allergic inflammation. J Allergy Clin Immunol 99(3):273-277
30. Tsukahara T, Makino Y, Fujii T, Ogawa M, Saisho H, Hamano Y, Ueda S, Akikusa B, Danoff TM (2002) Role of RANTES in the development of autoimmune tissue injuries in MRL-Fas lpr mice. Clin Immunol 103(1):89-97
31. Kameyoshi Y, Dorschner A, Mallet AI, Christophers E, Schroder JM (1992) Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med 176(2):587-592
32. Roscic-Mrkic B, Fischer M, Leemann C, Manrique A, Gordon CJ, Moore JP, Proudfoot AE, Trkola A (2003) RANTES (CCL5) utilizes the proteoglycan CD44 as an auxiliary receptor to mediate cellular activation signals and HIV-1 enhancement. Blood 102(4):1169-1177
33. Stellato C, Collins P, Ponath PD, Soler D, Newman W, La Rosa G, Li H, White J, Schwiebert LM, Bickel C, Liu M, Bochner BS, Williams T, Schleimer RP (1997) Production of the Novel C-C Chemokine MCP-4 by Airway Cells and Comparison of Its Biological Activity to Other C-C Chemokines. J Clin Invest 99(5):926-936
34. Wang JH, Trigg CJ, Devalia JL, Jordan S, Davies RJ (1994) Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthma. J Allergy Clin Immunol 94(6 Pt 1):1025-1034
35. Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ (1996) Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 14(1):27-35
36. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
37. Szalai C, Duba J, Prohaszka Z, Kalina A, Szabo T, Nagy B, Horvath L, Csaszar A (2001) Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis 158(1):233-239
38. al Sharif F, Ollier WE, Hajeer AH (1999) A rare polymorphism at position -28 in the human RANTES promoter. Eur J Immunogenet 26(5):373-374
39. McDermott DH, Beecroft MJ, Kleeberger CA, Al-Sharif FM, Ollier WE, Zimmerman PA, Boatin BA, Leitman SF, Detels R, Hajeer AH, Murphy PM (2000) Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS 14(14):2671-2678
40. Noris M, Bernasconi S, Casiraghi F, Sozzani S, Gotti E, Remuzzi G, Mantovani A (1995) Monocyte chemoattractant protein-1 is excreted in excessive amounts in the urine of patients with lupus nephritis. Lab Invest 73(6):804-809